Personalized follow-up to prevent type 2 diabetes in adults
Tests a nurse-led personalized follow-up program in adults at risk of type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Key facts
- Where
- Biarritz, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT05325710, who can take part
Where in France
- Clinique AguiléraBiarritz, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Trial code
- NCT05325710
- Record updated
- 13 April 2022
- Original description
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis.Read full original descriptionShow less
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis.
The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life.
From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.
This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.
Inclusion: Patient, male or female, over the age of 18; Patient with a FINDRISC score ≥10 points; Beneficiary of a French health insurance system; Patient having been informed and having given their consent free, enlightened and written.
Exclusion: Patient already diagnosed with type 2 diabetes; Patient over 75 years old; Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant; Patient participating in another research; Patient in period of exclusion from another research always in progress at the time of inclusion; Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration; Pregnant, breastfeeding or parturient women; Patient hospitalized without consent.